-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Industry Careers

Program: Trainee Activities and Services
Session: Career Development Lunch
Saturday, December 9, 2023, 11:15 AM-12:15 PM

Ifeyinwa Osunkwo, MD, MPH

Ify Osunkwo MD, MPH, formerly Director SCD Enterprise Atrium Health; Currently Chief Patient Officer / SVP Forma therapeutics, Colts Neck, MA

Disclosures: Osunkwo: Novo Nordisk: Consultancy, Current Employment, Current equity holder in publicly-traded company, Honoraria; Forma Therapeutics: Consultancy, Ended employment in the past 24 months, Honoraria; Global Blood Therapeutics: Consultancy, Speakers Bureau; Novartis: Consultancy, Honoraria; Takeda: Consultancy; Cheisi: Consultancy; Emmaus: Consultancy, Speakers Bureau; Agios: Consultancy; Acceleron: Consultancy.